News

In the United States, until recently, your chances of receiving a donated liver within 30 days would vary significantly depending on where you lived—they could have been as low as 1 percent, or as high as 60. But a new liver distribution policy has made a huge shift, making distribution more equitable.

We interviewed Tomoaki Kato, MD, about what's new in liver treatment, and there have been big changes. Dr. Kato discusses everything from the rise in liver cancer to the cure for hepatitis C to advancements in surgery. There's a lot to be excited about and much to know.

Dr. Tomoaki Kato spent two months in the hospital fighting COVID-19. In this incredible essay, he tells his story and shares what he's learned along the way.

Recipients and donors mark 30 years since the first-ever living liver transplantation.

The liver is an extraordinary organ; its ability to regenerate makes living liver transplants possible. But in a country where 15 percent of people who need a liver transplant will die waiting for one, living liver transplants still only make up 5-7 percent of transplants. Dr. Emond, head of transplantation and pioneer in living liver surgery, urges a culture shift.

Liver donation is a gift of life. For irreversible liver diseases—like cirrhosis and hepatitis, but also congenital diseases present at birth—liver donation can be life-saving. While the results of liver transplantation can be miraculous and curative, equally astonishing is that successful transplantation can occur using just a portion of the donor liver.

The Department of Surgery at Columbia University Irving Medical Center (CUIMC) is very pleased to announce a gift to create the Newmyer Family Fellowship for Innovation in Surgery, with gratitude to donor Arthur G. (“Terry”) Newmyer III.

The Center for Liver Disease and Transplantation at NYP/Columbia is making noteworthy progress in the treatment of hepatocellular cancer (HCC) and cholangiocarcinoma (CCA), cancer of the bile duct, and is the national leader in this field.

The Center for Liver Disease and Transplantation at NYP/Columbia has created a new program to help pediatric liver transplant patients transition to adult care.

The Center for Liver Disease and Transplantation (CLDT) in collaboration with pediatric surgery at NYP/Columbia is making noteworthy advances in the care of children with serious liver conditions, and is a national leader in this field. “Our superior outcomes are the result of unique surgical training, high patient volume, and unsurpassed multidisciplinary collaboration,” says Jean C. Emond, MD, Chief of Transplantation Services at Columbia. “The CLDT brings together leading experts hepatobiliary surgery, hepatology, gastroenterology, oncology, radiology, diagnostic testing and pathology to provide exceptional patient care.”